ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

'Medicines for All', the Pharma Industry and the Indian State

When we consider that expenditure on medicines in India accounts for 50% to 80% of treatment costs, India's pharmaceutical success has clearly not translated into availability or affordability of medicines for all. As part of Universal Access to Healthcare, good quality healthcare should be accessible, affordable, and available to all in need. Providing quality medicines to all - free at the point of service - in all our public facilities is an achievable task. This article estimates the cost of providing free and quality medicines at all levels of public healthcare and offers suggestions on how this can be done.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

649for India

$20for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top